CN102542131A - Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network - Google Patents
Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network Download PDFInfo
- Publication number
- CN102542131A CN102542131A CN2010105833916A CN201010583391A CN102542131A CN 102542131 A CN102542131 A CN 102542131A CN 2010105833916 A CN2010105833916 A CN 2010105833916A CN 201010583391 A CN201010583391 A CN 201010583391A CN 102542131 A CN102542131 A CN 102542131A
- Authority
- CN
- China
- Prior art keywords
- drug molecule
- descriptor
- value
- medicament
- neural network
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The invention provides a method for predicting medicament pharmacokinetic properties and toxicity on the basis of genetic algorithm (GA) and an artificial neural network (ANN), which comprises the steps of (1) calculating medicament molecular descriptors; (2) preprocessing a data set of the medicament molecular descriptors; (3) scaling the data set of the medicament molecular descriptors again; (4) simultaneously optimizing the molecular descriptors and parameters of the artificial neural network by utilizing an integrated method; and (5) establishing a model by utilizing selected optimized medicament molecular descriptors and parameters of the artificial neural network and predicting the medicament pharmacokinetic properties and the toxicity. The method makes fully uses of advantages of the genetic algorithm, the artificial neural network and a computer, enables the medicament molecular descriptors and the parameters of the artificial neural network to simultaneously achieve an optimized state, and greatly improves predication effects and efficiency.
Description
Technical field
The present invention relates to area of computer aided SARS drug design field; Specifically relate to a kind ofly, be applicable to according to drug molecular structure information medicament molecule pharmacokinetic property and toxicity are predicted based on the medicament molecule pharmacokinetic property of genetic algorithm and artificial neural network and the Forecasting Methodology of toxicity.
Background technology
The general both at home and abroad at present prediction medicament molecule pharmacokinetic property and the method for toxicity are directly to set up model with artificial neural network to predict.This prediction of carrying out with single method can only make the parameter of ANN reach the optimization state, and the drug molecule descriptor is not optimized, and can produce two problems like this: the 1. interference problem of unrelated drugs molecule descriptor.In a large amount of drug molecule descriptor that calculates; Some drug molecule descriptor and medicament molecule pharmacokinetic property and toxicity do not have correlativity, and the adding of these drug molecule descriptors not only can't promote model predictive ability, interference model on the contrary; What cause predicting is inaccurate. therefore; The drug molecule descriptor of input model is not the more the better, should be optimized as the case may be. 2. sample size problem. when the drug molecule descriptor of input model more for a long time, then in order to obtain better prediction; Must increase considerably sample; And this often is difficult to satisfy in reality, because pharmacokinetics and toxicity test data test difficulty and expense are higher, has limited obtaining of great amount of samples.
Summary of the invention
In order to solve the optimization problem of drug molecule descriptor, the object of the invention aims to provide a kind of drug pharmacokinetics character and toxicity prediction method based on genetic algorithm and artificial neural network.
At the initial stage of drug development, use a computer and predict the pharmacokinetic property and the toxicity of drug molecule, can reduce the risk of later stage drug development, reduce R&D costs.Genetic algorithm and artificial neural network are combined; Make full use of the survival of the fittest principle of genetic algorithm; And the unique advantage of the statistical learning ability of artificial neural network and the outside huge data of computing machine fast processing; Drug molecule descriptor and artificial neural network parameter are optimized, make the both reach the optimization state, thereby the forecast quality of medicament molecule pharmacokinetic property and toxicity and forecasting efficiency are greatly improved.Practice effect proves, the present invention predicts that medicament molecule pharmacokinetic property and toxicity accuracy rate are high, saves time, laborsaving, and has preferable generalization and than a kind of Forecasting Methodology of high-timeliness.
The object of the invention can be realized through following technical scheme:
A kind of drug pharmacokinetics character and toxicity prediction method based on genetic algorithm and artificial neural network may further comprise the steps:
(1) calculating of drug molecule descriptor;
(2) pre-service of drug molecule descriptive data collection; Value with (a) drug molecule descriptor serves as zero above 90%; (b) with the related coefficient of other medicines molecule descriptor greater than 90% standard, deletion does not have the drug molecule descriptor of researching value;
(3) scale again of drug molecule descriptive data collection; The descriptive data collection is mapped in [1 ,+1] interval, its mapping formula is:
Wherein: x is the original value of drug molecule descriptor, x
PreBe again the value after the scale, x
MaxAnd x
MinThe maximal value and the minimum value of the corresponding drug molecule descriptor of difference.
(4) adopt integrated approach simultaneously drug molecule descriptor and artificial neural network parameter to be optimized, may further comprise the steps:
I is provided with the population size, end condition, ANN parameter area.Population comprises 20 individuals, and end condition is that the value of fitness within 100 generations is not changing, and the ANN parameter area is 2-10;
The ii chromosome of encoding: the drug molecule descriptor is used binary coding, and the corresponding binary-coded character of each drug molecule descriptor is selected if this drug molecule is described, and then is expressed as 1, otherwise is 0, and the ANN parameter adopts decimal coded;
Iii initialization population: produce 20 individuals at random;
Iv sets up model, calculates each individual fitness function in the initial population through the RMSE value that is produced by each model, and its computing formula is:
fitness＝w
r×RMSE+w
f×N
Wherein: RMSE is the predicted root mean square error of leaving-one method cross validation, and N is the number of the molecule descriptor of selection, w
rAnd w
fIt is respectively corresponding weight factor;
Whether v inspection satisfies end condition, if satisfy condition then withdraw from, otherwise the operation below continuing;
Vi adopts the elite strategy to carry out selection operation, and selecting in former generation, to have, the individuality of high fitness value appears at the next generation all the time;
Vii adopts intersect at random at 5, and the individuality of selecting is carried out interlace operation;
Viii adopts traditional single-point variation, and the individuality of selecting is carried out interlace operation, produces new population;
Ix forwards the iv step to;
(5) when satisfying end condition, promptly optimum drug molecule descriptor and ANN parameter are definite, and optimum model is set up, and the drug molecule descriptor input model of the medicine that needs are predicted promptly draws its pharmacokinetic property and toxicity value;
The advantage that the present invention compared with prior art has:
The survival of the fittest thought of genetic algorithm is incorporated into medicament molecule pharmacokinetic property and toxicity prediction system; Effectively utilize the statistical learning ability of artificial neural network and the unique advantage of the outside huge data of computing machine fast processing; Drug molecule descriptor and artificial neural network parameter are optimized; Make the both reach the optimization state, the forecast quality of medicament molecule pharmacokinetic property and toxicity and forecasting efficiency are greatly improved.Predictablity rate can reach more than 85%, and the drug molecule descriptor number that uses reduces more than 95% than other method.The method has crucial effect to area of computer aided SARS drug design and original new drug research and development.
Description of drawings
Fig. 1 drug molecule descriptor and ANN parameter optimization process flow diagram
Fig. 2 utilizes the present invention to realize the process flow diagram based on genetic algorithm and neural network prediction medicament molecule pharmacokinetic property and toxicity.
Fig. 3 is based on the medicament molecule pharmacokinetic property of genetic algorithm and neural network and the figure that predicts the outcome of toxicity.
Fig. 3 a is the figure as a result that microbiotic and the interactional action constant of DNA and the action constant value of measuring through experiment of model prediction compared;
Fig. 3 b is the IC of the BRAF suppressant of model prediction
50Value and the IC that measures through experiment
50The figure as a result that value is compared;
The EC of the enterovirus suppressant of Fig. 3 c model prediction
50Value and the EC that measures through experiment
50The figure as a result that value is compared.
Embodiment
In order to make the object of the invention, technical scheme and advantage clearer, technical scheme of the present invention is further described again below in conjunction with accompanying drawing.
A kind of medicament molecule pharmacokinetic property and toxicity prediction method based on genetic algorithm and artificial neural network is:
(1) collects drug molecule, set up extensive sample set, utilize the computed in software molecule descriptor of drug molecule descriptor.Collected 30 kinds of microbiotic, 30 kinds of BRAF suppressant and 21 kinds of enterovirus suppressant, the structure through Hyperchem draws each drug molecule adopts HF/6-31G among the structure input Gaussian with each drug molecule
*Carry out the optimization of molecular conformation, seek the minimum energy state of each drug molecule.After optimizing end, calculate the drug molecule descriptor with optimizing among the good conformation importing MODEL.Calculated the electronics descriptor, ingredient descriptor, topological index descriptor, physicochemical property descriptor, geometrical molecular descriptor, quantum chemistry descriptor, six big types of 3778 kinds of drug molecule descriptors altogether.The electronics descriptor comprises that dipole moment, electric density connect index, topological electric charge index etc.; The ingredient descriptor comprises number of rings, atomicity, hydrogen bond number, atomic weight, hydrogen bond donor, hydrogen bond receptor of drug molecule etc.; The topological index descriptor comprises that Schultz Topological Index, Gutman Topological Index, Balaban molecule connection index, Wiener chemical bond index, CHI molecule connect index, kappa shape index, Hosoya Molecular Graphs index, Zagreb Molecular Graphs index, Moreau-Broto topology auto-correlation descriptor, Moran topology auto-correlation descriptor etc.; The physicochemical property descriptor comprises profit partition factor, polarizability; The geometrical molecular descriptor comprises principal moments of inertia, drug molecule volume, drug molecule surface area etc.; The quantum chemistry descriptor comprises highest occupied molecular orbital, lowest unoccupied molecular orbital, gross energy etc.
(2) said medicine molecule descriptive data collection is carried out pre-service; The value great majority of deletion drug molecule descriptor be 0 or with the related coefficient of other medicines molecule descriptor greater than 90% drug molecule descriptor; Carry out pretreated purpose and be drug molecule descriptor that deletion do not have researching value to reduce redundance, improve the accuracy rate of prediction.After the present invention carries out pre-service to 3778 drug molecule descriptors, also surplus 1777 drug molecule descriptors.
(3) to predict the outcome more accurately in order making, above-mentioned 1777 drug molecule descriptors to be carried out scale again, the data set that is about to comprise 1777 drug molecule descriptors passes through formula:
Be mapped in [1 ,+1] interval, wherein x is the original value of drug molecule descriptor, x
PreBe again the value after the scale, x
MaxAnd x
MinThe maximal value and the minimum value of the corresponding drug molecule descriptor of difference.
So far, accomplish the pre-service of drug molecule descriptor and the scale again of drug molecule descriptive data collection, also promptly accomplished preliminary preparation.
(4) adopt integrated method to carry out drug molecule descriptor and ANN parameter optimization, set up computer program prediction medicament molecule pharmacokinetic property and toxicity.
The end condition and the aberration rate of optimizing process at first are set, and end condition is not changing for the value of fitness within 100 generations, and aberration rate is 2%.Coding chromosome use binary coding with 1777 drug molecule descriptors, and the neuron node number composition chromosome of decimally encoding produces the initial population that comprises 20 individuals, genetic algebra K=1 at this moment then at random.The individuality that in the initial population each is comprised drug molecule descriptor subclass and ANN parameter is trained and is set up model, calculates each individual fitness value, fitness=w
r* RMSE+w
f* N, wherein: RMSE is the predicted root mean square error of leaving-one method cross validation, N is the number of the molecule descriptor of selection, w
rAnd w
fBe respectively corresponding weight factor, w
r=0.02, w
f=0.45.Whether inspection satisfies end condition, if satisfy end condition, then optimizing process stops, if do not satisfy then genetic algebra K=K+1, and the operation below continuing.Press the individuality in the big minispread initial population of fitness value, adopt elite policy selection 2 individuals, selecting in former generation, to have, the individuality of high fitness value appears at the next generation all the time.2 individuals of selecting are carried out 5 intersections and are produced new individual.Population is carried out traditional single-point variation according to 2% aberration rate, be about to 0 and become 1, or become 01.Repeat above process with new population, within 100 generations, do not change up to the value of fitness.
The value of the Fitness predictive ability of the bright model of novel more is strong more; Carrying out along with optimizing process; The value of fitness can diminish gradually, and the fitness value will no longer change when drug molecule descriptor and ANN parameter reach optimum state, explains that best model sets up.With the microbiotic of needs prediction, the molecule descriptor input model of BRAF suppressant and enterovirus suppressant promptly draws microbiotic and the interactional action constant value of DNA, the IC of BRAF suppressant
50The EC of value and enterovirus suppressant
50Value.Predicted results is fine, and wherein the predicated error of 95% sample is less than 0.5.Fig. 3 a-c is through 30 kinds of microbiotic of model prediction and the interactional action constant of DNA, the IC of 30 kinds of BRAF suppressant
50The EC of value and 21 kinds of enterovirus suppressant
50Value and the figure as a result that compares through the value that experiment is measured.Wherein Fig. 3 a is the figure as a result that microbiotic and the interactional action constant of DNA and the action constant value of measuring through experiment of model prediction compared; Fig. 3 b is the IC of the BRAF suppressant of model prediction
50Value and the IC that measures through experiment
50The figure as a result that value is compared; The EC of the enterovirus suppressant of Fig. 3 c model prediction
50Value and the EC that measures through experiment
50The figure as a result that value is compared.Usually, right-angle coordinate representation is used in predicting the outcome of medicament molecule pharmacokinetic property and toxicity, and horizontal ordinate is the value that experiment is surveyed, and ordinate is the value through model prediction.When the value that value through model prediction and experiment are surveyed approaching more, error more hour, it is tight more that sample point distributes in the diagonal line both sides, the linear effects of the comparison diagram of being done is good more.Square and pentagram are sample point of the present invention among Fig. 3 a-c.Can find out that from Fig. 3 a-c the figure that the point of square and pentagram is become becomes good linear relationship, and all sample points all are distributed in cornerwise both sides.Explanation predicts that with the present invention medicament molecule pharmacokinetic property and toxicity are a kind of good methods, can improve the forecast quality and the forecasting efficiency of medicament molecule pharmacokinetic property and toxicity.In addition, Fig. 3 a-c is compared also and can find out: the linear relationship of Fig. 3 b is best, and it is tightr that sample point distributes in the diagonal line both sides, and its reason is that the predicated error of 30 BRAF suppressant of model prediction is all in 0.3.
Claims (1)
1. medicament molecule pharmacokinetic property and toxicity prediction method based on a GA and an ANN the steps include:
(1) calculating of drug molecule descriptor;
(2) pre-service of drug molecule descriptive data collection: the value with (a) drug molecule descriptor serves as zero above 90%; (b) with the related coefficient of other medicines molecule descriptor greater than 90% standard, deletion does not have the drug molecule descriptor of researching value to reduce redundance;
(3) scale again of drug molecule descriptive data collection; Drug molecule descriptive data collection is mapped in [1 ,+1] interval, and its mapping formula is:
Wherein x is the original value of drug molecule descriptor, x
PreBe again the value after the scale, x
MaxAnd x
MinThe maximal value and the minimum value of the corresponding drug molecule descriptor of difference;
(4) adopt integrated approach, simultaneously drug molecule descriptor and artificial neural network parameter are optimized; May further comprise the steps:
I is provided with the population size, end condition, ANN parameter area;
The ii chromosome of encoding: the drug molecule descriptor is used binary coding, and the corresponding binary-coded character of each drug molecule descriptor is selected if this drug molecule is described, and then is expressed as 1, otherwise is 0, and the ANN parameter adopts decimal coded;
Iii initialization population: produce 20 individuals at random;
Iv sets up model, calculates each individual fitness function in the initial population through the RMSE value that is produced by each model, and its computing formula is:
fitness＝w
r×RMSE+w
f×N
Wherein: RMSE is the predicted root mean square error of leaving-one method cross validation, and N is the number of the drug molecule descriptor of selection, w
rAnd w
fIt is respectively corresponding weight factor;
Whether v inspection satisfies end condition, if satisfy condition then withdraw from, otherwise the operation below continuing;
Vi adopts the elite strategy to carry out selection operation, and selecting in former generation, to have, the individuality of high fitness value appears at the next generation all the time;
Vii adopts intersect at random at 5, and the individuality of selecting is carried out interlace operation;
Viii adopts traditional single-point variation, and the individuality of selecting is carried out mutation operation, produces new population;
Ix forwards the iv step to;
(5) model of being set up with optimum drug molecule descriptor and ANN parameter, prediction medicament molecule pharmacokinetic property and toxicity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105833916A CN102542131A (en) | 2010-12-07 | 2010-12-07 | Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105833916A CN102542131A (en) | 2010-12-07 | 2010-12-07 | Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102542131A true CN102542131A (en) | 2012-07-04 |
Family
ID=46349005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105833916A Pending CN102542131A (en) | 2010-12-07 | 2010-12-07 | Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102542131A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104897791A (en) * | 2015-03-25 | 2015-09-09 | 中国中医科学院中药研究所 | Simulation and prediction method for pharmacokinetic curve of traditional Chinese medicine |
| CN109979541A (en) * | 2019-03-20 | 2019-07-05 | 四川大学 | Medicament molecule pharmacokinetic property and toxicity prediction method based on capsule network |
| CN110648725A (en) * | 2019-08-21 | 2020-01-03 | 复旦大学 | Method and system for guiding optimization of substance structure based on structure and pharmacokinetics |
| CN111243682A (en) * | 2020-01-10 | 2020-06-05 | 京东方科技集团股份有限公司 | Method, device, medium and apparatus for predicting toxicity of drug |
| CN112420131A (en) * | 2020-11-20 | 2021-02-26 | 中国科学技术大学 | Molecular generation method based on data mining |
| CN114360661A (en) * | 2022-01-06 | 2022-04-15 | 中国人民解放军国防科技大学 | Molecular structure prediction method based on group intelligent optimization model and related equipment |
| CN114550847A (en) * | 2022-01-28 | 2022-05-27 | 中国人民解放军军事科学院国防科技创新研究院 | Medicine oral availability and toxicity prediction method based on atlas neural network |
| CN114550847B (en) * | 2022-01-28 | 2024-04-16 | 中国人民解放军军事科学院国防科技创新研究院 | Medicine oral availability and toxicity prediction method based on graph convolution neural network |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101329699A (en) * | 2008-07-31 | 2008-12-24 | 四川大学 | Method for predicting medicament molecule pharmacokinetic property and toxicity based on supporting vector machine |
| CN101528899A (en) * | 2005-07-29 | 2009-09-09 | 埃克森美孚研究工程公司 | Method to determine predictive tests and device applying same to lubricant formulations |
-
2010
- 2010-12-07 CN CN2010105833916A patent/CN102542131A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101528899A (en) * | 2005-07-29 | 2009-09-09 | 埃克森美孚研究工程公司 | Method to determine predictive tests and device applying same to lubricant formulations |
| CN101329699A (en) * | 2008-07-31 | 2008-12-24 | 四川大学 | Method for predicting medicament molecule pharmacokinetic property and toxicity based on supporting vector machine |
Non-Patent Citations (3)
| Title |
|---|
| 刘朝晖 等: "药代动力学建模的人工神经网络新方法", 《中国临床药理学杂志》 * |
| 吴瑞清: "人工神经网络在临床药学中的应用", 《海峡药学》 * |
| 赵春燕: "QSAR研究在生命分析化学和环境化学中的应用", 《中国优秀博士学位论文全文数据库》 * |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104897791B (en) * | 2015-03-25 | 2017-01-04 | 中国中医科学院中药研究所 | A kind of Chinese medicines is for dynamic (dynamical) curve simulation and Forecasting Methodology |
| CN104897791A (en) * | 2015-03-25 | 2015-09-09 | 中国中医科学院中药研究所 | Simulation and prediction method for pharmacokinetic curve of traditional Chinese medicine |
| CN109979541B (en) * | 2019-03-20 | 2021-06-22 | 四川大学 | Method for predicting pharmacokinetic property and toxicity of drug molecules based on capsule network |
| CN109979541A (en) * | 2019-03-20 | 2019-07-05 | 四川大学 | Medicament molecule pharmacokinetic property and toxicity prediction method based on capsule network |
| CN110648725A (en) * | 2019-08-21 | 2020-01-03 | 复旦大学 | Method and system for guiding optimization of substance structure based on structure and pharmacokinetics |
| CN110648725B (en) * | 2019-08-21 | 2023-06-16 | 复旦大学 | Structure and pharmacokinetics-based material structure optimization guidance method and system |
| CN111243682A (en) * | 2020-01-10 | 2020-06-05 | 京东方科技集团股份有限公司 | Method, device, medium and apparatus for predicting toxicity of drug |
| CN112420131A (en) * | 2020-11-20 | 2021-02-26 | 中国科学技术大学 | Molecular generation method based on data mining |
| CN112420131B (en) * | 2020-11-20 | 2022-07-15 | 中国科学技术大学 | Molecular generation method based on data mining |
| CN114360661A (en) * | 2022-01-06 | 2022-04-15 | 中国人民解放军国防科技大学 | Molecular structure prediction method based on group intelligent optimization model and related equipment |
| CN114360661B (en) * | 2022-01-06 | 2022-11-22 | 中国人民解放军国防科技大学 | Molecular structure prediction method based on group intelligent optimization model and related equipment |
| CN114550847A (en) * | 2022-01-28 | 2022-05-27 | 中国人民解放军军事科学院国防科技创新研究院 | Medicine oral availability and toxicity prediction method based on atlas neural network |
| CN114550847B (en) * | 2022-01-28 | 2024-04-16 | 中国人民解放军军事科学院国防科技创新研究院 | Medicine oral availability and toxicity prediction method based on graph convolution neural network |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cai et al. | Solving nonlinear water management models using a combined genetic algorithm and linear programming approach | |
| CN102542131A (en) | Method for predicting medicament pharmacokinetic properties and toxicity on basis of genetic algorithm and artificial neural network | |
| Kollat et al. | A computational scaling analysis of multiobjective evolutionary algorithms in long-term groundwater monitoring applications | |
| Jung et al. | Prediction of building energy consumption using an improved real coded genetic algorithm based least squares support vector machine approach | |
| Ghadimi et al. | PSO based fuzzy stochastic long-term model for deployment of distributed energy resources in distribution systems with several objectives | |
| Jana et al. | Modified particle swarm optimization algorithms for the generation of stable structures of carbon clusters, Cn (n= 3–6, 10) | |
| He et al. | Probability density forecasting of wind power based on multi-core parallel quantile regression neural network | |
| Ismail et al. | A hybrid model of self organizing maps and least square support vector machine for river flow forecasting | |
| Zhang et al. | Dynamic graph convolutional networks based on spatiotemporal data embedding for traffic flow forecasting | |
| Wang et al. | Short-term wind power forecasting based on clustering pre-calculated CFD method | |
| CN110619419B (en) | Passenger flow prediction method for urban rail transit | |
| Hou et al. | Data‐driven affinely adjustable distributionally robust framework for unit commitment based on Wasserstein metric | |
| Yao et al. | Hybrid model for displacement prediction of tunnel surrounding rock | |
| CN102708269B (en) | Based on SVM prediction cytosolic phospholipase A2The method of the inhibition concentration of alpha inhibitor | |
| Wang et al. | Study on the coordinated development of urbanization and water resources utilization efficiency in China | |
| Liu et al. | A three-stage hybrid model for space-time analysis of water resources carrying capacity: A case study of Jilin Province, China | |
| CN115456312A (en) | Short-term power load prediction method and system based on octyl geometric modal decomposition | |
| CN107276093B (en) | The Probabilistic Load calculation method cut down based on scene | |
| Huang et al. | Techno-economic analysis of photovoltaic hydrogen production considering technological progress uncertainty | |
| Zhang et al. | Economic optimal allocation of mine water based on two-stage adaptive genetic algorithm and particle swarm optimization | |
| CN109034497A (en) | Prediction technique, system, medium and the equipment of polycrystalline reduction process energy consumption value | |
| Wu et al. | Application of marginal rate of transformation in decision making of multi-objective reservoir optimal operation scheme | |
| Kadkhodazadeh et al. | A novel hybrid framework based on the ANFIS, discrete wavelet transform, and optimization algorithm for the estimation of water quality parameters | |
| Liao et al. | Reliability optimization of multi-energy system considering energy storage devices effects under weather uncertainties | |
| CN109615142A (en) | A kind of wind farm wind velocity combination forecasting method based on wavelet analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120704 |